Data availability
Not applicable.
References
Abida W, Cheng ML, Armenia J et al (2019) Analysis of the prevalence of microsatellite instability in prostate cancer and response to immune checkpoint blockade. JAMA Oncol 5:471–478. https://doi.org/10.1001/jamaoncol.2018.5801
Wyvekens N, Tsai HK, Sholl LM et al (2022) Histopathological and genetic features of mismatch repair-deficient high-grade prostate cancer. Histopathology 80:1050–1060. https://doi.org/10.1111/his.14645
van Dessel LF, van Riet J, Smits M et al (2019) The genomic landscape of metastatic castration-resistant prostate cancers reveals multiple distinct genotypes with potential clinical impact. Nat Commun 10:5251. https://doi.org/10.1038/s41467-019-13084-7
Erson-Omay EZ, Henegariu O, Omay SB et al (2017) Longitudinal analysis of treatment-induced genomic alterations in gliomas. Genome Med 9:12. https://doi.org/10.1186/s13073-017-0401-9
Graham LS, Montgomery B, Cheng HH et al (2020) Mismatch repair deficiency in metastatic prostate cancer: response to PD-1 blockade and standard therapies. PLoS ONE 15:e0233260. https://doi.org/10.1371/journal.pone.0233260
Author information
Authors and Affiliations
Contributions
AMA diagnosed the cases and wrote this correspondence.
Corresponding author
Ethics declarations
Ethics statement
Not applicable (not a research study).
Conflict of interest
The author declares no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Acosta, A.M. Primary mismatch repair–deficient prostate cancer can be identified prospectively in prostate biopsies and radical prostatectomies. Virchows Arch (2024). https://doi.org/10.1007/s00428-024-03789-6
Received:
Revised:
Accepted:
Published:
DOI: https://doi.org/10.1007/s00428-024-03789-6